Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Police say violent crime improving in downtown Raleigh, but more work is needed
Recommended
Back to school guide: Buses, lunches, key dates
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aadi Biosciences Inc
(NQ:
AADI
)
1.470
+0.020 (+1.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aadi Biosciences Inc
< Previous
1
2
Next >
Stocks That Hit 52-Week Lows On Monday
March 06, 2023
On Monday, 36 companies set new 52-week lows.
Via
Benzinga
5 Value Stocks In The Healthcare Sector
January 30, 2023
Via
Benzinga
Aadi Bioscience: Q2 Earnings Insights
August 10, 2022
Aadi Bioscience (NASDAQ:AADI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Aadi Bioscience: Q1 Earnings Insights
May 12, 2022
Aadi Bioscience (NASDAQ:AADI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Aadi Bioscience beat estimated...
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Aadi Bioscience, Lowers Price Target To $48
April 11, 2022
HC Wainwright & Co. has decided to maintain its Buy rating of Aadi Bioscience (NASDAQ:AADI) and lower its price target from $49.00 to $48.00. Shares of Aadi Bioscience are trading down 4.87% over the...
Via
Benzinga
Aadi Bioscience: Q4 Earnings Insights
March 17, 2022
Aadi Bioscience (NASDAQ:AADI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ICPT, AKBA, QURE, BNTX, SAVA)
January 19, 2022
Via
AB Newswire
Topics
Bonds
Stocks
Exposures
Debt Markets
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 02, 2021
Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million...
Via
Benzinga
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, & More
November 28, 2021
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant helped mitigate the losses notched earlier in the holiday-shortened week.
Via
Talk Markets
Exposures
COVID-19
Product Safety
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
November 28, 2021
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses...
Via
Benzinga
Exposures
COVID-19
Product Safety
What 4 Analyst Ratings Have To Say About Aadi Bioscience
November 24, 2021
Analysts have provided the following ratings for Aadi Bioscience (NASDAQ:AADI
Via
Benzinga
Aadi Bioscience Stock Pops On First-Ever FDA Approval In Rare Cancer
November 23, 2021
Aadi Bioscience won FDA approval for a drug to treat rare tumors.
Via
Investor's Business Daily
Exposures
Product Safety
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 23, 2021
Good morning, investors! We're getting right back to the grind today with a dive into the biggest pre-market stock movers for Tuesday.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Aadi Bioscience Shares Rally On FDA Approval For Its First Product For Rare Form Cancer
November 23, 2021
The FDA has approved Aadi Bioscience Inc's (NASDAQ: AADI) Fyarro (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for perivascular...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...
Via
Benzinga
Exposures
Product Safety
76 Biggest Movers From Yesterday
November 11, 2021
Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...
Via
Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021
October 01, 2021
Upgrades Northland Capital Markets upgraded the previous rating for Five9 Inc (NASDAQ:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2021
September 08, 2021
Upgrades For SilverBow Resources Inc (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021
September 14, 2021
Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ...
Via
Benzinga
60 Biggest Movers From Friday
August 30, 2021
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.